Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats

British Journal of Pharmacology

Volumn 130, Issue 6, 2000, Pages 1305-1314

  Vickers, S P ^a   Benwell, K R ^a   Porter, R H ^a   Bickerdike, M J ^a   Kennett, G A ^a   Dourish, C T ^a  

^a Cerebrus Limited   (United Kingdom)

Author keywords

5 HT(2C); Chronic administration; d fenfluramine; Feeding; Locomotor activity; mCPP; Ro 60 0175; Serotonin; Thermogenesis; Tolerance

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2 CHLORO 5 FLUOROINDOL 1 YL 1 METHYLETHYLAMINE FUMARATE; FENFLURAMINE; SEROTONIN 2C AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FLUID INTAKE; FOOD INTAKE; HYPOPHAGIA; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THERMOGENESIS; WEIGHT GAIN;

ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; DRINKING; EATING; ETHYLAMINES; FENFLURAMINE; HYPOTHALAMUS; INDOLES; INFUSION PUMPS; MOTOR ACTIVITY; PIPERAZINES; RATS; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RNA, MESSENGER; SEROTONIN AGENTS; TIME FACTORS;

EID: 0033914588     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703443     Document Type: Article

References (51)

1. BARBHAIYA, R.H., BUCH, A.B. & GREENE, D.S. (1996). Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan. Br. J. Clin. Pharmacol., 42, 573-581.
2. BARKER, E.L. & SANDERS-BUSH, E. (1993). 5-Hydroxytryptamine 1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Mol. Pharmacol., 44, 725-730.
3. BERNARDIS, L.L. & BELLINGER, L.L. (1996). The lateral hypothalamic area revisited: ingestive behaviour. Neurosci. Biobehav. Rev., 20, 189-287.
4. BOESS, F.G. & MARTIN, I.L. (1994). Molecular biology of 5-HT receptors. Neuropharmacology, 33, 275-317.
5. CACCIA, S., BALLABIO, M., SAMANIN, R., ZANINI, M.G. & GARATTINI, S. (1981). (-)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J. Pharm. Pharmacol., 33, 477-478.
6. CALLAWAY, C.W., WING, L.L., NICHOLS, D.E. & GEYER, M.A. (1993). Suppression of behavioural activity by norfenfluramine and related drugs in rats is not mediated by serotonin release. Psychopharmacology. 111, 169-178.
7. CANTON, H., EMESON, R.B., BARKER, E.L. BACKSTROM, J.R., LU, J.T., CHANG, M.S. & SANDERS-BUSH, E. (1996). Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine 2C receptor produced by alternative splicing. Mol. Pharmacol., 50, 799-807.
8. DOURISH, C.T. (1995). Multiple serotonin receptors - opportunities for new treatments for obesity. Obesity Res., 3, S449-S462.
9. 2C receptor agonist Ro 60-0175 decreases meal size and accelerates the onset of the behavioural satiety sequence in the rat. Soc. Neurosci. Abstr., 24, 406.5.
10. 2C receptor levels in the rat. Br. J. Pharmacol., 123, 1707-1715.
11. FREO, U., HOLLOWAY, H.W., GREIG, N.H. & SONCRANT, T. (1992). Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioural and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin. Psychopharmacology, 107, 30-38.
12. 2C receptors in mice. Eur. J. Pharmacol., 341, 135-138.
13. GOODALL, E.M., COWAN, P.J., FRANKLIN, P.J. & SILVERSTONE, T. (1993). Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology, 112, 461-466.
14. GUNDLAH, C., MARTIN, K.F., HEAL, D.J. & AUERBACH, S.B. (1997). In vivo criteria to differentiate monoamine re-uptake inhibitors from releasing agents: sibutramine is a re-uptake inhibitor. J. Pharmacol. Exptl. Ther., 283, 581-597.
15. GUY-GRAND, B. (1992). Clinical studies with d-fenfluramine. Am. J. Clin. Nutr., 55, (Suppl 1), S173-S176.
16. HAGER, G., ECKERT, E. & SCHWAIGER, F-W. (1999). Semiquantitative analysis of low levels of mRNA expression from small amounts of brain tissue by nonradioactive reverse transcriptasepolymerase chain reaction. J. Neurosci. Methods, 89, 141-149.
17. 2C receptors in mediating fenfluramine-induced anorexia in the rat. Br. J. Pharmacol., 114, 373P.
18. HUTSON, P.H., DONOHOE, T.P. & CURZON, P.G. (1988). Infusion of the 5-hydroxytryptamine agonists RU 24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology, 95, 550-552.
19. KENNEDY, A.J., GIBSON, E.L., O'CONNELL, M.T. & CURZON, G. (1993). Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP. Br. J. Pharmacol., 113, 262-268.
20. 1C receptors and their therapeutic relevance. Curr. Opin. Invest. Drugs, 2, 317-362.
21. 1C receptors. Br. J. Pharmacol., 94, 137-147.
22. 1B receptors. Psychopharmacology, 96, 93-100.
23. 2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology, 36, 233-239.
24. 2C receptor antagonist. Neuropharmacology, 36, 609-620.
25. LUCAS, J.J., YAMAMOTO, A., SCEARCE-LEVIE, K., SAUDOU, F. & HEN, R. (1998). Absence of fenfluramine-induced anorexia and reduced c-fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knockout mice. J. Neurosci., 18, 5537-5544.
26. 2C receptor agonists: pharmacological characteristics and therapeutic potential. J. Pharmacol. Exp. Ther., 286, 913-924.
27. MARTIN, G.R. & HUMPHREY, P.P.A. (1994). Receptors of 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology, 33, 261-273.
28. MCGUIRK, J., MUSCAT, R. & WILLNER, P. (1992). Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence. Psychopharmacology, 106, 401-407.
29. MENNINI, T., BIZZI, A., CACCIA, S., CODEGONI, A., FRACASSO, C., FRITTOLI, E., GUISO, G., PADURA, I.M., TADDEI, C., USLENGHI, A. & GARATTINI, S. (1991). Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs. Naunyn-Schmeid. Arch. Pharmacol., 343, 483-490.
30. NEILL, J.C. & COOPER, S.J. (1989). Evidence that d-fenfluramineanorexia is mediated by 5-HT1 receptors. Psychopharmacology, 85, 111-114.
31. 2C receptors in CHO-K1 cells. Br. J. Pharmacol., 128, 13-20.
32. 1C/2 receptor agonists and antagonists. Eur. J. Pharmacol., 244, 1-5.
33. ROTHWELL, N.J. & LE FEUVRE, R.A. (1992). Thermogenesis, brown adipose tissue and dexfenfluramine in animal studies. Int. J. Obes. Relat. Metab. Disord., 16 (Suppl. 3), S67-S71.
34. ROWLAND, N.E. (1986). Effect of continuous infusions of dexfenfluramine on food intake, body weight and brain amines in rats. Life Sci., 39, 2581-2586.
35. ROWLAND, N.E. & CARLTON, J. (1986a). Tolerance to fenfluramine anorexia: fact or fiction?. Appetite, 7 (Suppl), 71-83.
36. ROWLAND, N.E. & CARLTON, J. (1986b). Neurobiology of an anorectic drug: fenfluramine. Prog. Neurobiol., 27, 13-62.
37. SABOL, K.E., RICHARDS, R.B. & SEIDEN, L.S. (1992). Fluoxetine attenuates the d, l-fenfluramine-induced increase in extracellular serotonin as measured by in vivo microdialysis. Brain Res., 585, 421-424.
38. 2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology, 133, 309-312.
39. SAUCIER, C. & ALBERT, P.R. (1997). Identification of an endogenous 5-hydroxytryptamine2A receptor in NIH-3T3 cells: agonist-induced down-regulation involves decreases in receptor RNA and number. J. Neurochem., 68, 1998-2011.
40. SCALFI, L., D'ARRIGO, E., CARADENTE, V., COLTORTI, A. & CONTALDO, F. (1993). The acute effect of dexfenfluramine on resting metabolic rate and postprandial thermogenesis in obese subjects: a double-blind placebo-controlled study. Int. J. Obes. Relat. Metab. Disord., 17, 91-96.
41. 1A agonists. J. Pharmacol. Exptl. Ther., 273, 101-112.
42. SILLS, M.A., LUCKI, I. & FRAZER, A. (1985). Development of selective tolerance to the serotonin behavioural syndrome and suppression of locomotor activity after repeated administration or either 5-MeODMT or mCPP. Life Sci., 36, 2463-2469.
43. SIMANSKY, K. (1998). Serotonin and the structure of satiation. In Satiation: From Gut to Brain, ed. Smith, G.P. pp. 217-262. Oxford: Oxford University Press.
44. STALLONE, D.D. & LEVITSKY, D.A. (1994). Chronic fenfluramine treatment: effects on body weight, food intake and energy expenditure. Int. J. Ob., 18, 679-685.
45. 2C serotonin receptors. Nature, 374, 542-546.
46. 1B receptor ligands on appetite control in the rat. Br. J. Pharmacol., 123, 238P.
47. UTSUGISAWA, K., TOHGI, H., YOSHIMURA, M., NAGANE, Y. & UKITSU, M. (1999). Quantitation of nicotinic acetylcholine receptor subunits α4 and β2 messenger RNA in postmortem human brain using a non-radioactive RT-PCR and CCD imaging system. Brain Res. Protoc., 4, 92-96.
48. 2C receptor mutant mice. Psychopharmacology, 143, 309-314.
49. WEINTRAUB, M., RUBIO, A., GOLIK, A., BYRNE, L. & SCHEINBAUM, M.L. (1991). Sibutramine in weight control; a dose ranging efficacy study. Clin. Pharmacol. Ther., 50, 330-337.
50. 2A receptor agonists into the medial prefrontal cortex produces a head twitch response in rats. J. Pharmacol. Exptl. Ther., 282, 699-706.
51. 2C receptor: Complete cDNA, genomic structure, and alternatively spliced variant. Genomics, 35, 551-561.